244 related articles for article (PubMed ID: 18692170)
1. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
So CY; Leung PW; Hung SF
Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
[TBL] [Abstract][Full Text] [Related]
2. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
3. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
Liu C; Robin AL; Brenner S; Eastman J
Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
[TBL] [Abstract][Full Text] [Related]
4. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.
Van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Rev; 2008 Jun; 28(5):783-800. PubMed ID: 18068284
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate and behavior modification on the social and academic behavior of children with disruptive behavior disorders: the moderating role of callous/unemotional traits.
Waschbusch DA; Carrey NJ; Willoughby MT; King S; Andrade BF
J Clin Child Adolesc Psychol; 2007; 36(4):629-44. PubMed ID: 18088220
[TBL] [Abstract][Full Text] [Related]
10. Critical influences affecting response to various treatments in young children with ADHD: a case series.
Heriot SA; Evans IM; Foster TM
Child Care Health Dev; 2008 Jan; 34(1):121-33. PubMed ID: 18171453
[TBL] [Abstract][Full Text] [Related]
11. Interventions for preschool children at high risk for ADHD: a comparative effectiveness review.
Charach A; Carson P; Fox S; Ali MU; Beckett J; Lim CG
Pediatrics; 2013 May; 131(5):e1584-604. PubMed ID: 23545375
[TBL] [Abstract][Full Text] [Related]
12. Management of attention deficit hyperactivity disorder: a parental perspective.
Concannon PE; Tang YP
J Paediatr Child Health; 2005 Dec; 41(12):625-30. PubMed ID: 16398864
[TBL] [Abstract][Full Text] [Related]
13. [Neuropsychological assessment of the effectiveness of OROS-methylphenidate in attention deficit hyperactivity disorder].
Rubio-Morell B; Martín-González R; Herreros-Rodríguez O; González-Pérez P; Hernández-Exposito S; Quintero-Fuentes I; Gracia-Marco R
Rev Neurol; 2008 May 16-31; 46(10):602-8. PubMed ID: 18465700
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children.
Horn WF; Ialongo NS; Pascoe JM; Greenberg G; Packard T; Lopez M; Wagner A; Puttler L
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):233-40. PubMed ID: 2016227
[TBL] [Abstract][Full Text] [Related]
16. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
Kiliç BG; Bilgiç A; Gürkan K; Aysev A
Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
[TBL] [Abstract][Full Text] [Related]
17. Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country.
Chazan R; Borowski C; Pianca T; Ludwig H; Rohde LA; Polanczyk G
J Clin Psychopharmacol; 2011 Jun; 31(3):309-17. PubMed ID: 21508864
[TBL] [Abstract][Full Text] [Related]
18. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?].
Hansen L; Thomsen PH
Ugeskr Laeger; 2005 Nov; 167(48):4555-9. PubMed ID: 16324436
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
20. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
Berger I; Dor T; Nevo Y; Goldzweig G
J Child Neurol; 2008 Sep; 23(9):1036-42. PubMed ID: 18487521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
